Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report)’s share price was up 0.8% during mid-day trading on Thursday . The stock traded as high as C$2.66 and last traded at C$2.64. Approximately 67,005 shares changed hands during trading, an increase of 5% from the average daily volume of 63,699 shares. The stock had previously closed at C$2.62.
Medexus Pharmaceuticals Stock Performance
The company has a market capitalization of C$84.62 million, a PE ratio of 261.00 and a beta of 0.71. The company’s 50-day simple moving average is C$2.73 and its 200-day simple moving average is C$2.86.
Medexus Pharmaceuticals Company Profile
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc is a leading specialty pharmaceutical company with a strong North American commercial platform. It is focused on the therapeutic areas of auto-immune disease and pediatrics. The leading products are Rasuvo and Metoject, a unique formulation of methotrexate to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an innovative allergy medication with a unique mode of action.
Further Reading
- Five stocks we like better than Medexus Pharmaceuticals
- 10 Best Airline Stocks to Buy
- Why Amazon Could Be a $300 Stock Within Weeks
- 5 Top Rated Dividend Stocks to Consider
- Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside
- ETF Screener: Uses and Step-by-Step Guide
- MarketBeat Week in Review – 12/8 – 12/12
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
